| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2249.1991.TB05584.X |
| P698 | PubMed publication ID | 1988229 |
| P2093 | author name string | T A Merritt | |
| M Hallman | |||
| D S Strayer | |||
| P2860 | cites work | Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity | Q24561593 |
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Isolation of a cDNA clone encoding a high molecular weight precursor to a 6-kDa pulmonary surfactant-associated protein | Q28301346 | ||
| Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption | Q34584352 | ||
| Surfactant-anti-surfactant immune complexes in infants with respiratory distress syndrome | Q35835631 | ||
| Structure of canine pulmonary surfactant apoprotein: cDNA and complete amino acid sequence | Q36486933 | ||
| Pulsating bubble technique for evaluating pulmonary surfactant | Q36573848 | ||
| A proposed nomenclature for pulmonary surfactant-associated proteins | Q39548005 | ||
| Immunoregulatory properties of pulmonary surfactant: influence of variations in the phospholipid profile | Q41396431 | ||
| Hydrophobic proteins of lamellated osmiophilic bodies isolated from pig lung | Q42169310 | ||
| Antigenicity of low molecular weight surfactant species | Q42769723 | ||
| Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant | Q42853545 | ||
| Regulation of immune functions by human surfactant. | Q43992295 | ||
| Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo | Q45259873 | ||
| Immunomodulation by pulmonary surfactant. | Q45947412 | ||
| Characterization and partial amino acid sequence of a low molecular weight surfactant protein | Q47196065 | ||
| The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant. | Q47203590 | ||
| Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity | Q69421634 | ||
| Proteolipid in bovine lung surfactant: its role in surfactant function | Q69610875 | ||
| Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome | Q70247879 | ||
| Immunomodulatory effects of pulmonary surfactant on natural killer cell and antibody-dependent cytotoxicity | Q70251439 | ||
| Comparative adsorption of natural lung surfactant, extracted phospholipids, and artificial phospholipid mixtures to the air-water interface | Q71246804 | ||
| Lung surfactants. II. Effects of fatty acids, triacylglycerols and protein on the activity of lung surfactant | Q71248812 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 35-40 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Immunogenicity of surfactant. I. Human alveolar surfactant | |
| P478 | volume | 83 |
| Q74556252 | A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome |
| Q39479463 | Evidence for the existence of ganglioside molecules on Pneumocystis carinii from human lungs |
| Q35830285 | Identification of a cell membrane protein that binds alveolar surfactant |
| Q68183646 | Immunogenicity of surfactant. II. Porcine and bovine surfactants |
Search more.